Valuation: Farmacias Benavides, S.A.B. de C.V.

Market Cap 10.22B 553M 495M 461M 419M 782M 52.62B 793M 5.53B 2.16B 27.39B 2.08B 2.03B 87.44B P/E 2024
68.9x
P/E 2025 47.4x
Enterprise Value 11.96B 647M 579M 539M 490M 914M 61.55B 928M 6.47B 2.53B 32.04B 2.43B 2.38B 102B EV / Sales 2024
0.69x
EV / Sales 2025 0.64x
Free-Float
16.07%
Yield 2024 *
-
Yield 2025 -
10-07 Canada's Weston family to buy UK's Boots in $8.9 billion deal RE
07-31 Farmacias Benavides, S.A.B. de C.V. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
05-26 Mexico's Farmacias Benavides starts process to delist from official securities registry RE
04-30 Farmacias Benavides, S.A.B. de C.V. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
02-26 Farmacias Benavides, S.A.B. de C.V. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 CI
25-10-28 Farmacias Benavides, S.A.B. de C.V. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
25-07-28 Farmacias Benavides, S.A.B. de C.V. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
25-04-29 Farmacias Benavides, S.A.B. de C.V. Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
25-02-26 Farmacias Benavides, S.A.B. de C.V. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 CI
24-08-15 Farmacias Benavides, S.A.B. de C.V. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI
24-05-13 Farmacias Benavides, S.A.B. de C.V. Auditor Raises 'Going Concern' Doubt CI
24-04-25 Farmacias Benavides, S.A.B. de C.V. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
24-02-26 Farmacias Benavides, S.A.B. de C.V. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Manager TitleAgeSince
Chief Executive Officer - 2024-12-01
Director of Finance/CFO - 2026-03-16
Director of Finance/CFO - -
Director TitleAgeSince
Director/Board Member - 2020-12-31
Chairman - 2023-05-01
Director/Board Member - 2023-05-01
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 557M
+13.68%-1.09%+13.54%-23.57% 7.23B
+0.16%+1.87%-15.01%-3.81% 6.13B
-0.52%-0.94%-13.61%+1.28% 6.06B
+0.71%+9.09%+3.71%-8.99% 4.57B
+0.26%+4.34%+14.26%-21.76% 3.22B
-0.34%-1.28%-26.77%-9.80% 3.13B
-3.19%-5.04%-28.37%-38.76% 3.1B
+9.46%+12.52%-35.22%-7.86% 3.33B
+0.75%-0.90%-27.17%+25.68% 2.84B
Average +2.10%+3.40%-12.74%-9.73% 4.4B
Weighted average by Cap. +3.08%+3.94%-9.58%-10.13%

Financials

2024 2025
Net sales 17.65B 955M 855M 796M 723M 1.35B 90.85B 1.37B 9.55B 3.73B 47.29B 3.58B 3.51B 151B 19.46B 1.05B 942M 878M 797M 1.49B 100B 1.51B 10.53B 4.12B 52.15B 3.95B 3.87B 166B
Net income 131M 7.06M 6.32M 5.89M 5.35M 9.98M 672M 10.13M 70.66M 27.63M 350M 26.52M 25.94M 1.12B 224M 12.13M 10.85M 10.11M 9.18M 17.13M 1.15B 17.39M 121M 47.43M 601M 45.53M 44.54M 1.92B
Net Debt 3.26B 176M 158M 147M 134M 249M 16.78B 253M 1.76B 690M 8.74B 662M 648M 27.89B 1.73B 93.88M 84.01M 78.24M 71.08M 133M 8.93B 135M 939M 367M 4.65B 352M 345M 14.84B
Logo Farmacias Benavides, S.A.B. de C.V.
Farmacias Benavides SAB de CV is a Mexico-based company primarily engaged in the pharmaceutical and chemical industry. The Company operates a network of over 700 drug stores located nationwide under the Farmacias Benavides name. Through its network of drug stores, it sells a variety prescription and over the counter (OTC) medicines, cosmetics, personal and baby care products and toiletries, as well as it also provides such related services as laboratory samples, home delivery, prescription laboratory, online pharmacy and photo processing services. As of December 31, 2011, the Company owned such subsidiaries as Servicios Operacionales Benavides SA de CV, Benavides de Reynosa SA de CV and Servicios Logisticos Benavides SA de CV, and Fasa Investment Limitada which was its majority shareholder with 85.25% of its interest.
Employees
-